Eric Schadt - Net Worth and Insider Trading
Eric Schadt Net Worth
The estimated net worth of Eric Schadt is at least $829,614 dollars as of 2025-04-29. Eric Schadt is the President & Chief R&D Officer of GeneDx Holdings Corp and owns about 7,375 shares of GeneDx Holdings Corp (WGS) stock worth over $829,614. Details can be seen in Eric Schadt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eric Schadt has not made any transactions after 2022-05-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Eric Schadt
Eric Schadt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eric Schadt owns 1 companies in total, including GeneDx Holdings Corp (WGS) .
Click here to see the complete history of Eric Schadt’s form 4 insider trades.
Insider Ownership Summary of Eric Schadt
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| WGS | GeneDx Holdings Corp | 2022-05-20 | director & Chief Executive Officer |
Eric Schadt Latest Holdings Summary
Eric Schadt currently owns a total of 1 stock. Eric Schadt owns 7,375 shares of GeneDx Holdings Corp (WGS) as of May 20, 2022, with a value of $829,614.
Latest Holdings of Eric Schadt
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| WGS | GeneDx Holdings Corp | 2022-05-20 | 7,375 | 112.49 | 829,614 |
Holding Weightings of Eric Schadt
Eric Schadt Form 4 Trading Tracker
According to the SEC Form 4 filings, Eric Schadt has made a total of 4 transactions in GeneDx Holdings Corp (WGS) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in GeneDx Holdings Corp is the acquisition of 3,030 shares on May 20, 2022, which cost Eric Schadt around $192,000.
Insider Trading History of Eric Schadt
- 1
Eric Schadt Trading Performance
GuruFocus tracks the stock performance after each of Eric Schadt's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eric Schadt is -38.34%. GuruFocus also compares Eric Schadt's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eric Schadt within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Eric Schadt's insider trading performs compared to the benchmark.
Performance of Eric Schadt
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -17.1 | | | | | |
| Relative Return to S&P 500(%) | -11.29 | | | | | |
Eric Schadt Ownership Network
Ownership Network List of Eric Schadt
Ownership Network Relation of Eric Schadt
Eric Schadt Owned Company Details
What does GeneDx Holdings Corp do?
Who are the key executives at GeneDx Holdings Corp?
Eric Schadt is the director & Chief Executive Officer of GeneDx Holdings Corp. Other key executives at GeneDx Holdings Corp include director & Chief Executive Officer Katherine Stueland , Chief Financial Officer Kevin Feeley , and 10 percent owner Icahn School Of Medicine At Mount Sinai .
GeneDx Holdings Corp (WGS) Insider Trades Summary
Over the past 18 months, Eric Schadt made no insider transaction in GeneDx Holdings Corp (WGS). Other recent insider transactions involving GeneDx Holdings Corp (WGS) include a net sale of 111,231 shares made by Kevin Feeley , a net sale of 296,192 shares made by Katherine Stueland , and a net sale of 911,631 shares made by Opko Health, Inc. .
In summary, during the past 3 months, insiders sold 136,848 shares of GeneDx Holdings Corp (WGS) in total and bought 0 shares, with a net sale of 136,848 shares. During the past 18 months, 3,267,640 shares of GeneDx Holdings Corp (WGS) were sold and 555,642 shares were bought by its insiders, resulting in a net sale of 2,711,998 shares.
GeneDx Holdings Corp (WGS)'s detailed insider trading history can be found in Insider Trading Tracker table.
GeneDx Holdings Corp Insider Transactions
Eric Schadt Mailing Address
Above is the net worth, insider trading, and ownership report for Eric Schadt. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Eric Schadt's mailing address is: Stamford Ct 06902.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
